
    
      Patients with hypertrophic cardiomyopathy (HCM) and other inherited cardiac diseases are
      being studied under several research protocols to determine their pathogenesis and clinical
      manifestations. The purpose of this protocol is to determine the eligibility of patients with
      known or suspected inherited heart conditions for our research protocols.
    
  